Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

Oncogene

Volumn 22, Issue 51, 2003, Pages 8330-8336

  Crnkovic Mertens, Irena ^a   Hoppe Seyler, Felix ^a   Butz, Karin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Chemotherapy; HeLa; Inhibitors of apoptosis; Melanoma; RNA interference

Indexed keywords

CASPASE 3; DOXORUBICIN; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BIOTECHNOLOGY; CANCER CELL; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE LIVIN; PRIORITY JOURNAL; RNA ANALYSIS; RNA INTERFERENCE; TUMOR CELL; ULTRAVIOLET IRRADIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE, TUMOR; DNA PRIMERS; GENE SILENCING; HUMANS; IN SITU NICK-END LABELING; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 0344873763     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206973     Document Type: Article

References (48)

1. Agami R. (2002). Curr. Opin. Chem. Biol., 6, 829-834.
2. Ashhab Y, Alian A, Polliack A, Panet A and Yehuda DB. (2001). FEBS Lett., 495, 56-60.
3. Borkhardt A. (2002). Cancer Cell, 2, 167-168.
4. Brummelkamp TR, Bernards R and Agami R. (2002a). Cancer Cell, 2, 243-247.
5. Brummelkamp TR, Bernards R and Agami R. (2002b). Science, 296, 550-553.
6. Butz K, Denk C, Ullmann A, Scheffner M and Hoppe-Seyler F. (2000). Proc. Natl. Acad. Sci. USA, 97, 6693-6697.
7. Butz K and Hoppe-Seyler F. (1993). J. Virol., 67, 6476-6486.
8. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C and Hoppe-Seyler F. (1999). Oncogene, 18, 2381-2386.
9. Chen C and Okayama H. (1987). Mol. Cell Biol., 7, 2745-2752.
10. Deveraux QL and Reed JR. (1999). Genes Dev., 13, 239-252.
11. Du C, Fang M, Li Y and Wang X. (2000). Cell, 102, 33-42.
12. Elbashir SM, Harboth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
13. Elbashir SM, Harboth J, Weber K and Tuschl T. (2002). Methods, 26, 199-213.
14. Evan GI and Vousden KH. (2001). Nature, 411, 342-348.
15. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC. (1998). Nature, 391, 806-811.
16. Fulda S, Wick W, Weller M and Debatin M. (2002). Nat. Med., 8, 808-815.
17. Gazzaniga P, Gradilone A, Guilani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L and Agliano AM. (2003). Ann. Oncol., 14, 85-90.
18. Green DR and Evan GI. (2002). Cancer Cell, 1, 19-30.
19. Hannon GJ. (2002), Nature, 418, 244-251.
20. Herr I and Debatin K-M. (2001). Blood, 98, 2603-2614.
21. Igney FH and Krammer PH. (2002). Nat. Rev. Cancer, 2, 277-288.
22. Johnstone RW, Ruefi A and Lowe SW. (2002). Cell, 108, 153-164.
23. Kasof GM and Gomes BC. (2001). J. Biol. Chem., 276, 3238-3246.
24. LaCasse E, Baird S, Korneluk RG and MacKenzie AE. (1998). Oncogene, 17, 3247-3259.
25. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA and Herweijer A. (2002). Nat. Genet., 32, 107-108.
26. Lin J-H, Deng G, Huang Q and Morser J. (2000). Biochim. Biophys. Res. Commun., 279, 820-831.
27. McCaffrey AP, Meuse L, Pham T-TT, Conklin DS, Hannon GJ and Kay MA. (2002). Nature, 418, 38-39.
28. McManus MT and Sharp PA. (2002). Nat. Rev. Genet., 3, 737-747.
29. Morris MC, Chaloin L, Heitz F and Divita G. (2000). Curr. Opin. Biotechnol., 11, 461-466.
30. Nicholson DW. (2000). Nature, 407, 810-816.
31. Paddison PJ and Hannon GJ. (2002). Cancer Cell, 2, 17-23.
32. Reed JC. (2003). Cancer Cell, 3, 17-22.
33. Rittner K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R and Jacobs E. (2002). Mol. Ther., 5, 104-114.
34. Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender P and Khavari PA. (2000). Nat. Med., 11, 1253-1257.
35. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL and Wender PA. (2002). J. Med. Chem., 45, 3612-3618.
36. Salvesen GS and Duckett CS. (2002). Nat. Rev. Mol. Cell. Biol., 3, 401-410.
37. Sanna MG, da Silva Correia J, Ducrey O, Lee J, Nomoto K, Schrantz N, Deveraux QL and Ulevitch RJ. (2002). Mol. Cell. Biol., 22, 1754-1766.
38. Slee EA, Adrain C and Martin SJ. (1999). Cell Death Differ., 6, 1067-1074.
39. Song E, Lee S-K, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P and Lieberman J. (2003). Nat. Med., 10, 2002 Published Online February, 10.1038/nm828.
40. Southern PJ and Berg P. (1982). J. Mol. Appl. Genet., 1, 327-341.
41. Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM and Salvesen GS. (1999). J. Biol. Chem., 274, 8359-8362.
42. Tuschl T. (2002). Nat. Biotechnol., 20, 446-448.
43. Verhagen AM, Ekert PG, Pakusch M, Silke J, Conolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. (2000). Cell, 102, 43-53.
44. Verhagen AM and Vaux DL. (2002). Apoptosis, 7, 163-166.
45. Vucic D, Deshayes K, Ackerley H, Pisabarro MT, Kadkhodayan S, Fairbrother WJ and Dixit VM. (2002). J. Biol. Chem., 277, 12275-12279.
46. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS and Dixit VM. (2000). Curr. Biol., 10, 1359-1366.
47. Wilde M, Fuchs U, Wössmann W and Borkhardt A. (2002). Oncogene, 21, 5716-5724.
48. Xia H, Mao Q, Paulsen HL and Davidson BL. (2002). Nat. Biotechnol., 20, 1006-1010.